Expression of REV7 has prognostic significance in cervical cancer treated with intensity-modulated radiation therapy
The higher expression level of REV7 indicates an unfavorable prognosis in cervical cancer patients undergoing IMRT treatment. REV7 could potentially serve as a novel biomarker and therapeutic target for investigating the radiosensitivity of cervical cancer.
Authors
- Meihua Wang (ORCID: https://orcid.org/0009-0000-0485-0430)
- Yang Feng (ORCID: https://orcid.org/0000-0001-9381-7519)
- Wei Liu (ORCID: https://orcid.org/0000-0001-5659-6139)
- Tong Xiao (ORCID: https://orcid.org/0000-0003-1462-4650)
- Ling Chen (ORCID: https://orcid.org/0000-0002-2305-8251)
- Yuxing Yang
- Xue Huang (ORCID: https://orcid.org/0000-0002-5256-7362)
Institutions
- Second Hospital of Shandong University (CN)
- Changzhou No.2 People's Hospital (CN)
- Hangzhou Cancer Hospital (CN)
Publication Details
- Journal
- Discover Oncology
- Published
- 2025-04-05
- DOI
- https://doi.org/10.1007/s12672-025-02224-9
- Primary Topic
- Cancer-related molecular mechanisms research
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- National Natural Science Foundation of China